The Alnylam Pharmaceuticals 2024 “Interfering RNA & Rare Diseases” Prize has been awarded to Virginie Escriou, for her research entitled “Therapeutic strategies based on orally administered siRNA”. The prize was delivered at the Annual Scientific Symposium of the Fondation Maladies Rares on June 18, 2024.
